<DOC>
	<DOCNO>NCT02482155</DOCNO>
	<brief_summary>The main purpose study evaluate pharmacokinetic ( PK ) profile ibuprofen oral administration single dose MOMENT ACT ANALGESIC granules healthy male female subject , fast condition .</brief_summary>
	<brief_title>Ibuprofen ( MOMENT ACT ANALGESIC Granules ) Pharmacokinetic Study</brief_title>
	<detailed_description />
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>1 . Informed consent : sign write informed consent inclusion study ; 2 . Sex age : female male , 1855 year old inclusive ; 3 . Body Mass Index ( BMI ) : 18.530 kg/m2 inclusive ; 4 . Vital sign : systolic blood pressure ( SBP ) 100139 mmHg , diastolic blood pressure ( DBP ) 5089 mmHg , heart rate ( HR ) 5090 bpm , measure 5 min rest sit position ; 5 . Full comprehension : ability comprehend full nature purpose study , include possible risk side effect ; ability cooperate investigator comply requirement entire study ; 6 . Contraception fertility ( female ) : female childbearing potential must use least one follow reliable method contraception : 1. hormonal oral , implantable , transdermal , injectable contraceptive least 2 month screen visit ; 2. nonhormonal intrauterine device female condom spermicide contraceptive sponge spermicide diaphragm spermicide cervical cap spermicide least 2 month screen visit ; 3. male sexual partner agree use male condom spermicide ; 4. sterile sexual partner . Female participant nonchildbearing potential postmenopausal status least 1 year admit . For female subject , pregnancy test result must negative screen day 1 . 1 . Electrocardiogram ( ECG ) 12leads ( supine position ) : clinically significant abnormality ; 2 . Physical finding : clinically significant abnormal physical finding could interfere objective study ; 3 . Laboratory analysis : clinically significant abnormal laboratory value indicative physical illness ; 4 . Allergy : ascertain presumptive hypersensitivity active principle and/or formulation ' ingredient related drug , namely nonsteroidal antiinflammatory agent ( NSAIDs ) ; history anaphylaxis drug allergic reaction general , investigator considers may affect outcome study ; 5 . Diseases : history significant renal , hepatic , gastrointestinal ( particular gastroduodenal ulcer bleeding ) , cardiovascular , respiratory ( particular asthma ) , skin , haematological , endocrine neurological disease may interfere aim study ; 6 . Medications : medication , include counter ( OTC ) medication herbal product 2 week start study , particular ibuprofen . Hormonal contraceptives female allow ; 7 . Investigative drug study : participation evaluation investigational product 3 month study , calculate first day month follow last visit previous study ; 8 . Blood donation : blood donation 3 month study ; 9 . Drug , alcohol , caffeine , tobacco : history drug , alcohol [ &gt; 1 drink/day female &gt; 2 drinks/day male , define accord United States Department Agriculture Dietary Guidelines 2010 ] , caffeine ( &gt; 5 cup coffee/tea/day ) tobacco abuse ( &gt; =10 cigarettes/day ) ; daily use distil spirit ; 10 . Drug test : positive result drug test screening day1 ; 11 . Alcohol test : positive alcohol breath test day 1 ; 12 . Diet : abnormal diet ( &lt; 1600 &gt; 3500 kcal/day ) substantial change eat habit 4 week study , vegetarian ; 13 . Pregnancy ( female ) : positive miss pregnancy test screen day 1 , pregnant lactate woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>MOMENTACT</keyword>
	<keyword>ibuprofen 400 mg</keyword>
	<keyword>oral</keyword>
	<keyword>granule</keyword>
</DOC>